Ingredient suppliers Novozymes and Arla Foods Ingredients are collaborating to develop advanced protein ingredients by utilizing precision fermentation.
 
Novozymes specializes in precision fermentation, a technique which can fine-tune the molecular output of microorganisms to offer greater control of the fermentation process and enable tailor-made protein compositions. The company has been focused on developing new protein ingredients since 2019.
 
In partnership with Arla Foods Ingredients, it will contribute its expertise and create microbial strains for the production of proteins by precision fermentation at an industrial scale. Arla Foods Ingredients will contribute its food technology expertise, specifically related to the separation and drying process, and its knowledge of the regulatory landscape.
 
Initially, the two companies will focus on disease-specific medical nutrition, a category in which protein is especially important.
 
“This partnership brings together two market leaders in our respective areas. Collaborating with Novozymes fits perfectly with our ambition to explore alternative nutrition platforms and complement our portfolio of dairy and whey solutions. By leveraging our combined expertise, manufacturing skills and market insights, we’ll be able to accelerate the pace at which we bring innovative new protein products to market,” said Henrik Andersen, group vice president of Arla Foods Ingredients.
 
“Precision fermentation allows us to do almost anything in terms of protein composition and structure, and this is a fantastic opportunity to harness its full potential. In our ambition to develop new tailor-made products Arla Foods Ingredients is the best possible partner for us. It’s already firmly positioned in medical nutrition and offers substantial insight into market needs, as well as specific manufacturing capabilities that complement ours. Entering a partnership like this demonstrates the huge progress we’ve made since our decision to enter the health and nutrition space,” said Valerio Nannini, general manager at Novozymes Advanced Protein Solutions.